Literature DB >> 11180399

Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes.

J Harper1, L C Gerstenfeld, M Klagsbrun.   

Abstract

The expression of neuropilin-1 (NRP1), a recently described VEGF and semaphorin receptor expressed by endothelial cells (EC) but some non-EC types as well, was analyzed in osteoblasts in vitro and in vivo. Cultured MC3T3-E1 osteoblasts expressed NRP1 mRNA and bound VEGF(165) but not VEGF(121), characteristic of the VEGF isoform-specific binding of NRP1. These cells did not express VEGFR-1 or VEGFR-2 so that VEGF binding to osteoblasts was strictly NRP1-dependent. In a chick osteocyte differentiation system, NRP1 was expressed by osteoblasts but its expression was absent as the cells matured into osteocytes. Immunohistochemical localization of NRP1 within the developing bones of 36-day-old mice and embryonic Day 17 chicks demonstrated that NRP1 was expressed by osteoblasts migrating alongside invading blood vessels within the metaphysis of the growth plate, as well as by osteoblasts at the developing edge of trabeculae within the marrow cavity. On the other hand, NRP1 was not expressed by osteocytes in either species, consistent with the in vitro results. In addition to osteogenic cells, NRP1 expression by EC was observed throughout the bone. Together these results suggest that NRP1 might have a dual function in bone by mediating osteoblast function directly as well as angiogenesis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180399     DOI: 10.1002/1097-4644(20010401)81:1<82::aid-jcb1025>3.0.co;2-p

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation.

Authors:  Guangheng Li; Karin Corsi-Payne; Bo Zheng; Arvydas Usas; Hairong Peng; Johnny Huard
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

Review 2.  Regulation of bone remodeling by the central and peripheral nervous system.

Authors:  Florent Elefteriou
Journal:  Arch Biochem Biophys       Date:  2008-03-23       Impact factor: 4.013

3.  Fluid flow-induced soluble vascular endothelial growth factor isoforms regulate actin adaptation in osteoblasts.

Authors:  Mia M Thi; Sylvia O Suadicani; David C Spray
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

4.  Hypoxia increases Annexin A2 expression in osteoblastic cells via VEGF and ERK.

Authors:  Damian C Genetos; Alice Wong; Shinya Watari; Clare E Yellowley
Journal:  Bone       Date:  2010-09-15       Impact factor: 4.398

5.  Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.

Authors:  Diane R Bielenberg; Yasuhiro Hida; Akio Shimizu; Arja Kaipainen; Michael Kreuter; Caroline Choi Kim; Michael Klagsbrun
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice.

Authors:  Amelia L M Sutton; Xiaoxue Zhang; Diane R Dowd; Yogendra P Kharode; Barry S Komm; Paul N Macdonald
Journal:  Mol Endocrinol       Date:  2008-03-20

7.  Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation.

Authors:  Yanqiu Liu; Agnes D Berendsen; Shidong Jia; Sutada Lotinun; Roland Baron; Napoleone Ferrara; Bjorn R Olsen
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

8.  Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling.

Authors:  Kimberly A Jacobsen; Zainab S Al-Aql; Chao Wan; Jennifer L Fitch; Stephanie N Stapleton; Zachary D Mason; Robert M Cole; Shawn R Gilbert; Thomas L Clemens; Elise F Morgan; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

9.  A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro.

Authors:  Alun Hughes; Jennifer Kleine-Albers; Miep H Helfrich; Stuart H Ralston; Michael J Rogers
Journal:  Calcif Tissue Int       Date:  2012-01-07       Impact factor: 4.333

Review 10.  Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF.

Authors:  Ernestina Schipani; Christa Maes; Geert Carmeliet; Gregg L Semenza
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.